Related Experiment Video
Updated: Sep 30, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Proteins and pathways in atrial fibrillation and atrial cardiomyopathy underlying cryptogenic stroke
Elena Palà1, Jorge Pagola2, Jesus Juega2
1Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
Insights
This study identified novel proteins and pathways linked to atrial fibrillation and atrial cardiomyopathy in cryptogenic stroke patients. DPP7 was found at lower levels in atrial fibrillation, suggesting its potential as a biomarker.
Area of Science:
- Cardiology
- Biomarkers
- Stroke Etiology
Background:
- Atrial fibrillation (AF) is a primary cause of cryptogenic stroke.
- Atrial remodeling and cardiomyopathy also contribute to stroke risk.
- Identifying circulating biomarkers is crucial for understanding stroke mechanisms.
Purpose of the Study:
- To discover circulating proteins and pathways altered in AF and atrial cardiomyopathy.
- To investigate protein alterations in relation to left atrial volume index (LAVI) and peak atrial longitudinal strain (PALS).
- To identify potential biomarkers for cryptogenic stroke in AF patients.
Main Methods:
- A case-control study using aptamer arrays on 20 cryptogenic stroke patients (10 with AF, 10 without).
- Protein levels were compared between AF and non-AF groups and correlated with LAVI and PALS.
- Key findings were validated in a larger cohort of 111 patients.
Main Results:
- Forty-six proteins were differentially expressed in AF patients; DPP7 was validated as lower in AF.
- Fifty-seven proteins correlated with LAVI, and 270 with PALS.
- NT-proBNP was consistently found across analyses; altered pathways were noted in low PALS.
Conclusions:
- This study revealed multiple proteins and pathways associated with AF and atrial cardiomyopathy.
- DPP7 warrants further investigation as a potential biomarker for stroke etiology.
- The findings are hypothesis-generating for future research in cryptogenic stroke.
Background:
Atrial fibrillation (AF) is one of the most prevalent causes of cryptogenic stroke. Also, apart from AF itself, structural and remodelling changes in the atria might be an underlying cause of cryptogenic stroke. We aimed to discover circulating proteins and reveal pathways altered in AF and atrial cardiomyopathy, measured by left atrial volume index (LAVI) and peak atrial longitudinal strain (PALS), in patients with cryptogenic stroke.
Methods:
An aptamer array (including 1310 proteins) was measured in the blood of 20 cryptogenic stroke patients monitored during 28 days with a Holter device as a case-control study of the Crypto-AF cohort. Protein levels were compared between patients with (n = 10) and without AF (n = 10) after stroke, and the best candidates were tested in 111 patients from the same cohort (44 patients with AF and 67 without AF). In addition, in the first 20 patients, proteins were explored according to PALS and LAVI values.
Results:
Forty-six proteins were differentially expressed in AF cases. Of those, four proteins were tested in a larger sample size. Only DPP7, presenting lower levels in AF patients, was further validated. Fifty-seven proteins correlated with LAVI, and 270 correlated with PALS. NT-proBNP was common in all the discovery analyses performed. Interestingly, many proteins and pathways were altered in patients with low PALS.
Conclusions:
Multiple proteins and pathways related to AF and atrial cardiomyopathy have been revealed. The role of DPP7 as a biomarker for stroke aetiology should be further explored. Moreover, the present study may be considered hypothesis-generating.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coronary Artery Disease II: Pathophysiology
Clot Retraction and Fibrinolysis
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias